Amundi increased its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 185.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,008 shares of the company's stock after acquiring an additional 5,857 shares during the quarter. Amundi's holdings in Addus HomeCare were worth $1,139,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. Crossmark Global Holdings Inc. acquired a new position in shares of Addus HomeCare in the third quarter valued at $228,000. Victory Capital Management Inc. grew its stake in Addus HomeCare by 6.1% in the 3rd quarter. Victory Capital Management Inc. now owns 84,960 shares of the company's stock valued at $11,302,000 after buying an additional 4,913 shares during the last quarter. Royce & Associates LP raised its holdings in Addus HomeCare by 1.2% in the 3rd quarter. Royce & Associates LP now owns 8,924 shares of the company's stock valued at $1,187,000 after acquiring an additional 109 shares during the period. Empowered Funds LLC lifted its position in Addus HomeCare by 25.1% during the third quarter. Empowered Funds LLC now owns 13,887 shares of the company's stock worth $1,847,000 after acquiring an additional 2,790 shares during the last quarter. Finally, Natixis Advisors LLC boosted its holdings in shares of Addus HomeCare by 4.8% during the third quarter. Natixis Advisors LLC now owns 38,561 shares of the company's stock worth $5,130,000 after acquiring an additional 1,777 shares during the period. Institutional investors own 95.35% of the company's stock.
Addus HomeCare Price Performance
Addus HomeCare stock traded down $1.07 during mid-day trading on Friday, reaching $89.83. 434,769 shares of the company were exchanged, compared to its average volume of 148,784. The company has a fifty day simple moving average of $111.83 and a 200-day simple moving average of $121.87. Addus HomeCare Co. has a 12 month low of $87.88 and a 12 month high of $136.72. The firm has a market cap of $1.63 billion, a PE ratio of 20.56, a PEG ratio of 1.41 and a beta of 0.97.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). The business had revenue of $297.14 million during the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Sell-side analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current year.
Insider Buying and Selling at Addus HomeCare
In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the firm's stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the sale, the chief executive officer now owns 79,397 shares of the company's stock, valued at approximately $9,905,569.72. This trade represents a 23.95 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 4.60% of the company's stock.
Analysts Set New Price Targets
A number of equities analysts have recently weighed in on the company. Macquarie reiterated an "outperform" rating and set a $129.00 target price on shares of Addus HomeCare in a research note on Thursday, February 27th. JMP Securities assumed coverage on Addus HomeCare in a research note on Monday, December 16th. They set an "outperform" rating and a $150.00 target price on the stock. Oppenheimer increased their target price on Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. StockNews.com lowered Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Finally, Stephens reiterated an "overweight" rating and set a $142.00 target price on shares of Addus HomeCare in a research note on Wednesday, March 12th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $132.78.
Check Out Our Latest Stock Analysis on Addus HomeCare
Addus HomeCare Company Profile
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Articles
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
